TimeEvent

07:00 - 08:00

lifecellSapphire sponsor LifeCell satellite symposium: 'The reconstruction of challenging colorectal defects'.

08:00 - 09:00

Free papers (main auditorium)

Chairs: Peter Paul L. O. Coene (The Netherlands), Pedro Correia da Silva (Portugal)

  • F13: Natural history of sigmoid diverticulitis: 5-year results of a prospective monocentric cohort study - Pascal Gervaz (Geneva University Hospital, Switzerland)
  • F14: The financial impact of patient re-admissions with diverticulitis, a 5 year experience of a UK hospital - Qamar Iqbal (Hillingdon Hospital NHS Foundation Trust, UK)
  • F15: Diverticular Disease emergency surgery in NHS Scotland 2000 to 2010 - Hugh Paterson (University of Edinburgh, UK and Edinburgh Colorectal Surgery Unit, Western General Hospital, UK)
  • F16: Ambulatory treatment versus Hospitalisation for uncomplicated diverticulitis - Thomas Golda (Bellvitge University Hospital, Spain)
  • F17: Transanal endoscopic surgery with 3-d TEM or high definition 2-d TEO. Prospective randomized controlled study - Xavier Serra-Aracil (Parc Tauli University Hospital, Spain)
  • F18: Laparoscopic selection bias must be considered if colorectal performance is to be measured using reoperation rates - Thomas Pinkney (University Hospital Birmingham, Department of Colorectal Surgery, UK)

Free papers (parallel auditorium)

Chairs: Anton Stift (Austria), Filippo La Torre (Italy)

  • F19: Peutz-Jeghers syndrome and truncating mutations in STK11 - Sreelakshmi Mallappa (The Polyposis Registry, St Mark's Hospital, UK)
  • F20: Outcome of management for rectovaginal fistula after rectal cancer surgery: a multicenter study - Kyu Joo Park (Seoul National University College of Medicine, Republic of Korea)
  • F21: Antibiotic prophylaxis administered without proper timing does not reduse surgical site infections after appendectomy - Ondrej Ryska (Department of Surgery, 2nd Faculty of Medicine, Charles University and Central Military Hospital, Czech Republic)
  • F22: Rectovaginal fistula: is early stoma confection the best option for cure ? Results of 194 procedures in 55 consecutive women - Hélène Corte (Beaujon Hospital, Colorectal Department and University Paris VII, France)
  • F23: A 23-hour discharge protocol for loop ileostomy closures - Oliver Peacock (School of Graduate Entry Medicine & Health, University of Nottingham, Royal Derby Hospital, UK)
  • F24: Short-term postoperative complications in patients treated with azathioprine for Crohn’s disease - Giulia Vitali (Sant'Orsola-Malpighi Hospital General Surgery Prof. Poggioli, Italy)

09:00 - 10:00

Symposium - Proctology

Chairs: Jirí Hoch (Czech Republic), Bruno Roche (Switzerland)

  • Management of anal intra-epithelial neoplasia - Per J. Nilsson (Sweden)
  • Perineal skin disorders - Eva Csatar (Hungary)
  • Novel approaches for treatment of anal fistula (LIFT, stem cells, new plugs?) - Dimitri Christoforidis (Switzerland)
10:00 - 10:10

ESCP Honorary Membership Award

Presented by incoming President Søren Laurberg

10:10

Best of the Six Best Papers Award

Awarded by BJS Secretary Ronan O’Connell

BJSPrize courtesy of British Journal of Surgery

10:10 - 10:40

Keynote lecture: SNS - time for critical appraisal

Speaker: Klaus Matzel (Germany)
Chair: Freddy Penninckx (Belgium)medtronic

Supported by a grant from by Medtronic

10:40 - 10:45

ESCP Fellowship Update

Lars Påhlman (Sweden), Klaus Matzel (Germany)

covidienSupported by Covidien

10:45 - 11:05

Coffee/exhibition/posters

11:05 - 12:30

Consultants' corner

Convenors: Najib Haboubi (UK), Sarah O’Dwyer (UK), Mike Parker (UK)

ethicon

Panel: Torbjörn Holm (Sweden), Mehmet Ayhan Kuzu (Turkey), Stefan Post (Germany), Béla Teleky (Austria), Yury Shelygin (Russia), Alan Thorson (USA)

Supported by a grant from Ethicon

12:30 - 13:00

Keynote lecture: Metastatic CRC - what about the primary?

Speaker: Irinel Popescu (Romania)
Chair: Peter Dawson (UK)

Introduced by BJS Secretary Ronan O’Connell

BJSSupported by a grant from British Journal of Surgery

13:00 - 14:30

Long lunch/exhibition/posters

View poster titles and presenters

13:15 - 14:30

ethiconSapphire Sponsor Ethicon satellite symposium: 'Recent evidence for the benefits of laparoscopy in colonic and rectal resections: review of the LAFA and COLOR II trials'.

13:00 - 15:00

Trainee surgeons' workshop and lunch

Chair: Ed Fitzgerald

  • Complications in colorectal surgery; what a Trainee needs to know
  • Trainee update on the management of colorectal cancer

14:30 - 15:30

Free papers (main auditorium)

Chairs: Alexander Herold (Germany), Sergii Podpriatov (Ukraine)

  • F25: Diagnostic accuracy of benign anal pathology: the effect of colorectal outpatient clinic attendance by medical students - Constantine Spanos (1st Department of Surgery, Aristotelian University, Greece)
  • F26: Stapled haemorrhoidopexy: a prospective audit from a 10 years database - Pierpaolo Sileri (Surgery, University of Rome Tor Vergata, Italy)
  • F27: Pre-operative mapping of fistula in ano: a new 3D MRI imaging technique - Nicholas Day (Wirral University Teaching Hospital NHS Foundation Trust, UK)
  • F28: Laparoscopic ventral mesh rectopexy: the treatment of choice for the resolution of solitary rectal ulcer syndrome - Thomas Roe (Frenchay Hospital, UK)
  • F29: Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer - Sidse Bregendahl (Aarhus University Hospital, Denmark)
  • F30: Outcome of sacral nerve stimulation for faecal incontinence at five-year - Yasuko Maeda (Aalborg University Hospital, Denmark and St Mark’s Hospital, UK)

Free papers (parallel auditorium)

Chairs: Jean-Luc Faucheron (France), Josef Korcek (Slovakia)

  • F31: Could brain neuroplasticity be the mechanism involved in the control of continence by sacral nerve stimulation? Results of a prospective study in incontinent patients after switching the stimulator off - Ivana Giannini (University of Bari, Italy)
  • F32: Day-case laparoscopic ventral rectopexy: an achievable reality - Michael Powar (Cambridge University Hospitals, UK)
  • F33: Comparable outcomes of PTNS and SNS for Faecal Incontinence in two distinct patient cohorts - Alexander Hotouras (Academic Surgical Unit, Barts Heath NHS Trust, Queen Mary University of London, UK)
  • F34: Impact of rectopexy on sexual function - Hendrik A. Formijne Jonkers (Meander Medical Centre, The Netherlands)
  • F35: Does pelvic neuromonitoring contribute to quality assurance in rectal cancer surgery? - Daniel Kauff (University Medicine of the Johannes Gutenberg-University Mainz, Germany)
  • F36: Diversion colitis: endoscopy, morphology, microbiology, biochemistry - Alex Moscalev (National Scientific Center of Coloproctology, Russia)

15:30 - 16:30

Symposium: New technology

Chairs: Alexander Engel (Netherlands), Dainius Pavalkis (Lithuania)

  • Single-port transanal minimally invasive surgery for rectal tumours - Paolo Delrio (Italy)

  • Artificial anal sphincter - Paul-Antoine Lehur (France)

  • New laparoscopic energy devices - Dieter Hahnloser (Switzerland)

covidienSupported by a grant from Covidien

16:30 - 17:30

Oral posters (main auditorium)

Chairs: Ethem Gecin (Turkey), Evgeny Rybakov (Russia)

  • OP47: The efficacy of selective arterial embolisation in the treatment of lower gastrointestinal bleeding - Sanjay Adusumilli (University of Sydney, Australia and Westmead Hospital, Australia)
  • OP37: Identification of histopathologic indicators of oncologic bowel resection for submucosally invasive colorectal cancer - Shingo Tsujinaka (Jichi Medical University, Saitama Medical Center, Japan)
  • OP38: Management of malignant left colonic obstruction: is temporary colostomy followed by surgical resection the best option? - Jeremie Lefevre (Hopital Saint-Antoine, France)
  • OP39: Surgical resection of retrorectal tumors in adults: long term results in 47 patients - Jeremie Lefevre (Hopital Saint-Antoine, France)
  • OP40: Learning curve for robotic rectal cancer surgery - Rosa M Jimenez-Rodriguez (HU Virgen del Rocio, Spain)
  • OP41: Treatment of familial adenomatous polyposis based on results of genetic studies - Yuri Chubarov (National Scientific Center of Coloproctology, Russia)
  • OP42: Have early post-operative complications from laparoscopic rectal cancer surgery improved over the past 20 years? - Rosalyn Shearer (Aberdeen Royal Infirmary, UK)
  • OP43: Increased incidence of isolated lung metastases in lower rectal cancers below the peritoneal reflection: a prospectively collected database of 835 patients over 5 years in singapore - Aik-Yong Chok (Singapore General Hospital, Singapore)
  • OP44: Anastomotic leakage following curative resection for colonic cancer increases the rate of distant recurrence and long-term mortality - Peter-Martin Krarup (Bispebjerg Hospital, Denmark)
  • OP45: Sphincter function and neorectal sensation in Low anterior resection syndrome (LARS) - Katrine J. Emmertsen (Colorectal Surgical Department P, Aarhus University Hospital, Denmark)
  • OP46: Single-port colorectal surgery: a monocentric experience of 65 cases - Caroline Hatwell (Beaujon Hospital, Colorectal Department and University Paris VII, France)
  • OP48: Is laparoscopic surgery a risk factor for re-operation after elective colorectal surgery - Steph Michail (University Hospital Aintree, UK)

Oral posters (parallel auditorium)

Chairs: Jose M. Enriquez-Navascues (Spain), Marc Duinslaeger (Belgium)

  • OP49: Which patients who have rectoceles and obstructed defecation syndrome (ODS) actually need surgery - Liliana Bordeianou (Massachusetts General Hospital, USA)
  • OP50: Can proctographic criteria help predict the outcome of laparoscopic ventral rectopexy for internal rectal prolapse? - Frederic Ris (Department of Surgery, Geneva University hospitals, Switzerland and Department of Colorectal Surgery, Oxford University Hospitals, UK)
  • OP51: Elytrocele surgical correction by abdominal approach: 185 patients over a 10 years study - Diane Mege (Digestive Surgical Department, France)
  • OP53: Health-related quality of life after surgery for locally advanced primary rectal cancer and recurrent rectal cancer - Henriette Vind Thaysen (Aarhus University Hospital, Denmark)
  • OP54: Re-do (Revision) Surgery for Patients with Obstructed Defaecation Syndrome and Slow Colonic Transit - Mohamed Rabie (Queen Elizabeth the Queen Mother Hospital, UK and Ain Shams University, Egypt)
  • OP55: Anastomotic leakage after intersphincteric resection for low rectal cancer affects function and quality of life - Leon Maggiori (Beaujon Hospital - Paris 7 University, France)
  • OP56: The relationship between clinical symptoms and proctographic findings in patients with pelvic floor dysfunction - Gemma Faulkner (University Hospital of South Manchester, UK)
  • OP57: Laparoscopic ventral rectopexy using biological cross-linked mesh - Luana Franceschilli (Surgery, University of Rome Tor Vergata, Italy)
  • OP58: Close rectal dissection versus total mesorectal excision in ileal pouch-anal anastomosis: a randomized controlled trial - Sanne Bartels (Academic Medical Center, The Netherlands)
  • OP59: Restorative proctocolectomy (RPC) in patients with ulcerative colitis (UC): a cross sectional Danish population study on pouch function and quality of life - Søren Brandsborg (Aarhus University Hosptal, Denmark)
  • OP60: Has the role of a defunctioning stoma for large bowel Crohn’s disease changed in the biological era? - Marc Martí-Gallostra (Oxford Colorectal Center, UK and Hospital Universitari Vall Hebron, Spain)
  • OP35: Doppler-guided hemorrhoidal artery ligation with suture mucopexy vs. suture mucopexy alone for treatment of IIIº hemorrhoids. A prospective-randomized controlled trial - Felix Aigner (Department of Visceral, Transplant and Thoracic Surgery, Austria)

17:30

Closing ceremony

Søren Laurberg (President), Zoran Krivokpapic (Past President) Peter Dawson (Secretary), Donato Altomare (Programme Committee Chairman), Emmanuel Tiret (Past Programme Committee Chairman)